XTL Biopharmaceuticals Ltd. (TLV:XTLB)
Israel · Delayed Price · Currency is ILS · Price in ILA 4.500
-0.200 (-4.26%)
Sep 11, 2025, 5:04 PM IDT
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of 40.54 million as of September 12, 2025. Its market cap has decreased by -68.46% in one year.
Market Cap
40.54M
Enterprise Value
36.88M
Revenue
1.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.50
Market Cap Chart
Since August 30, 2005, XTL Biopharmaceuticals's market cap has decreased from 805.44M to 40.54M, a decrease of -94.97%. That is a compound annual growth rate of -13.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2025 | 40.54M | -50.27% |
| Dec 31, 2024 | 81.53M | 327.50% |
| Dec 31, 2023 | 19.07M | -14.63% |
| Dec 29, 2022 | 22.34M | -52.02% |
| Dec 30, 2021 | 46.56M | -7.60% |
| Dec 31, 2020 | 50.39M | 108.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 75.88B |
| Danel (Adir Yeoshua) | 2.89B |
| Kamada | 1.36B |
| BrainsWay | 990.45M |
| SofWave Medical | 980.61M |
| Bait Bakfar | 979.07M |
| Novolog (Pharm-Up 1966) | 757.12M |
| Ilex Medical | 708.32M |